Clinical Excellence in Cardiovascular Prevention and Lipidology
Update on HDL biology: structure , metabolism and function in health and disease
France 
Disclosure : Research funding and Advisory board: Merck, Pfizer, Kowa Pharmaceuticals
[More]
[Less]
60 slide(s) – 00:46:20 – English – 2012-02-09
After viewing this presentation the participant will be able to:
- Describe the ultrastructure of HDL particles and what the laboratory readings mean
- Outline steps in the metabolism of HDL
- Relate the atheroprotective and vasculoprotective effects of HDL and important mechanisms
- Review the cardiometabolic diseases with low/dysfunctional HDL
|
